Kore Private Wealth’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,716
Closed -$371K 348
2021
Q3
$371K Buy
2,716
+284
+12% +$35.8K 0.04% 289
2021
Q2
$260K Buy
2,432
+8
+0.3% +$768 0.03% 337
2021
Q1
$218K Buy
+2,424
New +$228K 0.03% 331
2020
Q4
Sell
-1,980
Closed -$204K 339
2020
Q3
$204K Hold
1,980
0.04% 250
2020
Q2
$200K Buy
1,980
+640
+48% +$57.3K 0.04% 233
2020
Q1
$90K Hold
1,340
0.02% 323
2019
Q4
$73K Buy
+1,340
New +$63.6K 0.01% 418
2019
Q2
Sell
-1,340
Closed -$40K 387
2019
Q1
$40K Hold
1,340
0.01% 419
2018
Q4
$40K Buy
+1,340
New +$42.5K 0.01% 407

Other funds holding DXCM

Kore Private Wealth's DXCM Position: Q4 2021 in Review

Kore Private Wealth sold out of DexCom (DXCM) in Q4 2021, closing a stake of 2,716 shares — an estimated $371K sold.

Kore Private Wealth first reported a position in DXCM in Q4 2018 and held it in 9 quarters. The position peaked at $371K in Q3 2021. 931 funds tracked by Wall St. Rank hold DXCM as of Q4 2021.

  • Kore Private Wealth reported no remaining DexCom position as of Q4 2021 after selling out during the quarter.
  • Kore Private Wealth sold 2,716 DexCom shares in Q4 2021, an estimated $371K.
  • Kore Private Wealth first reported a position in DexCom in Q4 2018 and held it in 9 quarters.
  • Kore Private Wealth's DexCom position peaked at $371K in Q3 2021.
  • 931 funds tracked by Wall St. Rank held DexCom as of Q4 2021.

Based on Kore Private Wealth's 13F filing for Q4 2021, filed 11 Feb 2022.